2012 Q2 Form 10-Q Financial Statement

#000144530512001561 Filed on May 08, 2012

View on sec.gov

Income Statement

Concept 2012 Q2 2011 Q2
Revenue $510.9M $447.2M
YoY Change 14.25% 13.61%
Cost Of Revenue $278.9M $246.9M
YoY Change 12.97% 13.03%
Gross Profit $232.0M $200.3M
YoY Change 15.83% 13.73%
Gross Profit Margin 45.41% 44.79%
Selling, General & Admin $156.8M $132.7M
YoY Change 18.2% 9.12%
% of Gross Profit 67.6% 66.24%
Research & Development $32.62M $26.19M
YoY Change 24.59% 13.35%
% of Gross Profit 14.06% 13.07%
Depreciation & Amortization $32.01M $23.95M
YoY Change 33.62% 19.77%
% of Gross Profit 13.8% 11.96%
Operating Expenses $189.5M $158.9M
YoY Change 19.26% 9.88%
Operating Profit $36.38M $41.43M
YoY Change -12.19% 29.93%
Interest Expense $11.44M $3.916M
YoY Change 192.06% -208.78%
% of Operating Profit 31.44% 9.45%
Other Income/Expense, Net -$12.83M -$5.756M
YoY Change 122.9% -1251.2%
Pretax Income $23.55M $35.68M
YoY Change -33.98% 24.02%
Income Tax $1.476M $8.384M
% Of Pretax Income 6.27% 23.5%
Net Earnings $22.57M $24.91M
YoY Change -9.41% -1.2%
Net Earnings / Revenue 4.42% 5.57%
Basic Earnings Per Share $0.20 $0.22
Diluted Earnings Per Share $0.20 $0.22
COMMON SHARES
Basic Shares Outstanding 113.1M shares 114.0M shares
Diluted Shares Outstanding 114.1M shares 115.1M shares

Balance Sheet

Concept 2012 Q2 2011 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $144.8M $415.8M
YoY Change -65.18% 128.84%
Cash & Equivalents $144.8M $415.8M
Short-Term Investments
Other Short-Term Assets $103.4M $101.5M
YoY Change 1.85% -17.55%
Inventory $251.9M $224.8M
Prepaid Expenses
Receivables $407.9M $345.5M
Other Receivables $0.00 $0.00
Total Short-Term Assets $908.1M $1.088B
YoY Change -16.52% 22.06%
LONG-TERM ASSETS
Property, Plant & Equipment $171.7M $165.1M
YoY Change 3.99% -18.51%
Goodwill $2.103B
YoY Change
Intangibles $638.8M
YoY Change
Long-Term Investments $1.100M $1.400M
YoY Change -21.43% -39.13%
Other Assets $41.56M $34.10M
YoY Change 21.87% -28.06%
Total Long-Term Assets $2.956B $2.218B
YoY Change 33.26% 3.86%
TOTAL ASSETS
Total Short-Term Assets $908.1M $1.088B
Total Long-Term Assets $2.956B $2.218B
Total Assets $3.864B $3.306B
YoY Change 16.88% 9.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $163.0M $149.2M
YoY Change 9.25% -11.45%
Accrued Expenses $423.5M $358.0M
YoY Change 18.3% 11.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $2.300M
YoY Change -100.0% 2200.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $602.8M $511.2M
YoY Change 17.92% 2.57%
LONG-TERM LIABILITIES
Long-Term Debt $934.0M $514.0M
YoY Change 81.71% -2.69%
Other Long-Term Liabilities $444.9M $373.0M
YoY Change 19.28% 1.06%
Total Long-Term Liabilities $1.379B $887.0M
YoY Change 55.45% -1.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $602.8M $511.2M
Total Long-Term Liabilities $1.379B $887.0M
Total Liabilities $1.982B $1.398B
YoY Change 41.73% 0.19%
SHAREHOLDERS EQUITY
Retained Earnings $1.525B
YoY Change
Common Stock $289.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.883B $1.908B
YoY Change
Total Liabilities & Shareholders Equity $3.864B $3.306B
YoY Change 16.88% 9.22%

Cashflow Statement

Concept 2012 Q2 2011 Q2
OPERATING ACTIVITIES
Net Income $22.57M $24.91M
YoY Change -9.41% -1.2%
Depreciation, Depletion And Amortization $32.01M $23.95M
YoY Change 33.62% 19.77%
Cash From Operating Activities $15.54M $42.65M
YoY Change -63.57% -13.66%
INVESTING ACTIVITIES
Capital Expenditures $5.228M $7.681M
YoY Change -31.94% -202.41%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$56.60M
YoY Change -100.0% 948.15%
Cash From Investing Activities -$5.228M -$64.28M
YoY Change -91.87% 398.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.632M $109.2M
YoY Change -98.51%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$10.20M -$3.811M
YoY Change 167.52% -87.17%
NET CHANGE
Cash From Operating Activities $15.54M $42.65M
Cash From Investing Activities -$5.228M -$64.28M
Cash From Financing Activities -$10.20M -$3.811M
Net Change In Cash $116.0K -$25.44M
YoY Change -100.46% -474.16%
FREE CASH FLOW
Cash From Operating Activities $15.54M $42.65M
Capital Expenditures $5.228M $7.681M
Free Cash Flow $10.31M $34.97M
YoY Change -70.51% -38.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2012Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
173153000 USD
CY2012Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
163003000 USD
CY2012Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
409888000 USD
CY2012Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
407867000 USD
CY2012Q2 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
6800000 USD
CY2012Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
423517000 USD
CY2012Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
411526000 USD
CY2012Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
277386000 USD
CY2012Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
286550000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-159000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-124000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-3789000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Net Of Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectNetOfTax
-4088000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-2169000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
-2169000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
56164000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
69930000 USD
CY2012Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
68186000 USD
CY2012Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
54086000 USD
CY2012Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
175419000 USD
CY2012Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
164290000 USD
CY2011Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3054000 USD
CY2012Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5476000 USD
CY2011Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
635000 USD
CY2012Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
867000 USD
CY2012Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1506000 shares
CY2011Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1922000 shares
CY2012Q2 us-gaap Assets
Assets
3864238000 USD
CY2012Q1 us-gaap Assets
Assets
3834198000 USD
CY2012Q1 us-gaap Assets Current
AssetsCurrent
862218000 USD
CY2012Q2 us-gaap Assets Current
AssetsCurrent
908064000 USD
CY2012Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
202000 USD
CY2012Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
202000 USD
CY2012Q2 us-gaap Basis Of Accounting
BasisOfAccounting
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Basis of Presentation</font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The condensed consolidated financial statements included herein have been prepared by PerkinElmer, Inc. (the &#8220;Company&#8221;), without audit, in accordance with accounting principles generally accepted in the United&#160;States of America (the &#8220;U.S.&#8221; or the "United States") and pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;). Certain information in the footnote disclosures of the financial statements has been condensed or omitted where it substantially duplicates information provided in the Company&#8217;s latest audited consolidated financial statements, in accordance with the rules and regulations of the SEC. These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and notes included in its Annual Report on Form 10-K for the fiscal year ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;">, filed with the SEC (the &#8220;</font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form&#160;10-K&#8221;). The balance sheet amounts at </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">January&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;"> in this report were derived from the Company&#8217;s audited </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> consolidated financial statements included in the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K. The condensed consolidated financial statements reflect all adjustments that, in the opinion of management, are necessary to present fairly the Company&#8217;s financial position, results of operations and cash flows for the periods indicated. The preparation of financial statements in conformity with U.S. Generally Accepted Accounting Principles (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts and classifications of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The results of operations for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;3, 2011</font><font style="font-family:inherit;font-size:10pt;">, respectively, are not necessarily indicative of the results for the entire fiscal year or any future period. The Company has evaluated subsequent events from </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;"> through the date of the issuance of these condensed consolidated financial statements and has determined that no material subsequent events have occurred that would affect the information presented in these condensed consolidated financial statements or would require additional disclosure. </font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Change in Accounting for Pension and Other Postretirement Benefits: </font><font style="font-family:inherit;font-size:10pt;">During the fourth quarter of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">fiscal year 2011</font><font style="font-family:inherit;font-size:10pt;"> the Company changed its method of recognizing defined benefit pension and other postretirement benefit costs. Accordingly, the financial data for all periods presented has been retrospectively adjusted to reflect the effect of these accounting changes. Actuarial gains and losses are measured annually as of fiscal year end and accordingly will be recorded in the fourth quarter, unless the Company is required to perform an interim remeasurement. This change in accounting method for pension and other postretirement benefits is described in more detail in Note 1 to the Company&#8217;s audited consolidated financial statements filed with the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K. For the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;3, 2011</font><font style="font-family:inherit;font-size:10pt;"> the retrospective changes in recognizing defined benefit pension and other postretirement benefit costs increased operating income from continuing operations by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$2.1 million</font><font style="font-family:inherit;font-size:10pt;">, net income by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$1.4 million</font><font style="font-family:inherit;font-size:10pt;">, basic earnings per share by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.01</font><font style="font-family:inherit;font-size:10pt;">, diluted earnings per share by </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.01</font><font style="font-family:inherit;font-size:10pt;"> and other comprehensive income by </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">$1.6 million</font><font style="font-family:inherit;font-size:10pt;">. There were no changes to the previously reported cash flows from operating, investing or financing activities for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;3, 2011</font><font style="font-family:inherit;font-size:10pt;">. </font></div><div style="line-height:120%;padding-top:12px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Immaterial Restatement:</font><font style="font-family:inherit;font-size:10pt;"> As disclosed in the Company's </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">2011</font><font style="font-family:inherit;font-size:10pt;"> Form 10-K, prior to the </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;font-style:normal;font-weight:normal;text-decoration:none;">fiscal year 2011</font><font style="font-family:inherit;font-size:10pt;"> annual financial statements, the Company had reported revenue and cost of revenue as single line items and had not broken out product and service revenue and related cost of revenue separately. Accordingly, the Company has restated previously reported revenue and cost of revenue for the period ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;3, 2011</font><font style="font-family:inherit;font-size:10pt;"> to separately report product revenue, service revenue, and the related cost of product revenue and cost of service revenue.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted Accounting Pronouncements: </font><font style="font-family:inherit;font-size:10pt;">During the quarter ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;"> the Company adopted new guidance applicable to certain of its health care businesses that recognize patient service revenue at the time the services are rendered where the Company does not assess the patient's ability to pay at the time of the sale. The new guidance requires the Company to present the provision for bad debts related to such revenue as a deduction from revenue (net of contractual allowances and discounts) on the statements of operations. The effects of the adoption on the Company's condensed consolidated statements of operations resulted in a decrease to revenue and a decrease to selling, general and administrative expenses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;1, 2012</font><font style="font-family:inherit;font-size:10pt;"> and a decrease to revenue and a decrease to selling, general and administrative expenses of </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;"> and </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">$0.7 million</font><font style="font-family:inherit;font-size:10pt;">, respectively, for the </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">three</font><font style="font-family:inherit;font-size:10pt;"> months ended </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April&#160;3, 2011</font><font style="font-family:inherit;font-size:10pt;">. Accordingly, the financial data for all periods presented has been retrospectively adjusted to reflect the effect of these accounting changes.</font></div><div style="line-height:120%;padding-top:12px;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Issued Accounting Pronouncements: </font><font style="font-family:inherit;font-size:10pt;">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board ("FASB") and are adopted by the Company as of the specified effective dates. Unless otherwise discussed, the Company believes that such recently issued pronouncements will not have a significant impact on the Company&#8217;s condensed consolidated financial position, results of operations and cash flows or do not apply to the Company&#8217;s operations.</font></div></div>
CY2012Q2 us-gaap Business Acquisition Contingent Consideration Potential Cash Payment
BusinessAcquisitionContingentConsiderationPotentialCashPayment
50800000 USD
CY2011Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
2900000 USD
CY2012Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
200000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
144757000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
142342000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
415848000 USD
CY2011Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
420086000 USD
CY2011Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4238000 USD
CY2012Q2 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2415000 USD
CY2011Q2 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
-1908000 USD
CY2012Q2 us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
0 USD
CY2012Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
279000 USD
CY2011Q2 us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-4629000 USD
CY2012Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2011Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.07
CY2012Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.07
CY2012Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2011Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2011Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2011Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2012Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2012Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2012Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
113831000 shares
CY2012Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
113157000 shares
CY2012Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113831000 shares
CY2012Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
113157000 shares
CY2012Q2 us-gaap Common Stock Value
CommonStockValue
113831000 USD
CY2012Q1 us-gaap Common Stock Value
CommonStockValue
113157000 USD
CY2012Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36669000 USD
CY2011Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
72553000 USD
CY2011Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
246867000 USD
CY2012Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
278876000 USD
CY2012Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
186457000 USD
CY2011Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
157252000 USD
CY2011Q2 us-gaap Cost Of Services
CostOfServices
89615000 USD
CY2012Q2 us-gaap Cost Of Services
CostOfServices
92419000 USD
CY2012Q2 us-gaap Deferred Compensation Sharebased Arrangements Liability Current And Noncurrent
DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
5700000 USD
CY2012Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32007000 USD
CY2011Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23953000 USD
CY2008Q2 us-gaap Derivative Instruments Loss Recognized In Other Comprehensive Income Effective Portion
DerivativeInstrumentsLossRecognizedInOtherComprehensiveIncomeEffectivePortion
8400000 USD
CY2011Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
-1584000 USD
CY2012Q2 us-gaap Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax
DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
535000 USD
CY2012Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
42000 USD
CY2011Q2 us-gaap Discontinued Operation Tax Effect Of Discontinued Operation
DiscontinuedOperationTaxEffectOfDiscontinuedOperation
794000 USD
CY2012Q2 us-gaap Dividends Payable Amount
DividendsPayableAmount
8100000 USD
CY2011Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.22
CY2012Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2011Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2012Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
CY2012Q1 us-gaap Goodwill
Goodwill
2093626000 USD
CY2012Q2 us-gaap Goodwill
Goodwill
2103059000 USD
CY2012Q2 us-gaap Goodwill Translation Adjustments
GoodwillTranslationAdjustments
9433000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
22076000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
27291000 USD
CY2011Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
35675000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
23552000 USD
CY2012Q2 us-gaap Future Amortization Expense Year Four
FutureAmortizationExpenseYearFour
62900000 USD
CY2012Q2 us-gaap Future Amortization Expense Year One
FutureAmortizationExpenseYearOne
65900000 USD
CY2012Q2 us-gaap Future Amortization Expense Year Three
FutureAmortizationExpenseYearThree
77700000 USD
CY2012Q2 us-gaap Future Amortization Expense Year Two
FutureAmortizationExpenseYearTwo
85500000 USD
CY2011Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
21205000 USD
CY2012Q2 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2299000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000 USD
CY2011Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
200000 USD
CY2012Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1900000 USD
CY2011Q2 us-gaap Employee Service Share Based Compensation Tax Benefit From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense
1000000 USD
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
1139000 USD
CY2011Q2 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
7772000 USD
CY2011Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
7772000 USD
CY2012Q2 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
1139000 USD
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
338000 USD
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
291000 USD
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
0 USD
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Purchases
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
15531000 USD
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
0 USD
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
-1908000 USD
CY2012Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
20298000 USD
CY2011Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
15645000 USD
CY2011Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1731000 USD
CY2012Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
20636000 USD
CY2012Q2 us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
23400000 USD
CY2011Q2 us-gaap Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
16400000 USD
CY2012Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
491729000 USD
CY2012Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
514573000 USD
CY2012Q2 us-gaap Future Amortization Expense Year Five
FutureAmortizationExpenseYearFive
52300000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.20
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.24
CY2012Q2 us-gaap Interest Expense
InterestExpense
11437000 USD
CY2012Q2 us-gaap Inventory Net
InventoryNet
251858000 USD
CY2012Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.19
CY2011Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.24
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
-2378000 USD
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax
IncomeLossFromDiscontinuedOperationsNetOfTax
493000 USD
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0.00
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
-0.02
CY2012Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0.00
CY2011Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
-0.02
CY2012Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1476000 USD
CY2011Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8384000 USD
CY2011Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-16330000 USD
CY2012Q2 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11719000 USD
CY2012Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5850000 USD
CY2011Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24609000 USD
CY2012Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12970000 USD
CY2011Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9743000 USD
CY2012Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
661607000 USD
CY2012Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
638763000 USD
CY2011Q2 us-gaap Interest Expense
InterestExpense
3916000 USD
CY2012Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
160369000 USD
CY2012Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
153194000 USD
CY2012Q1 us-gaap Inventory Net
InventoryNet
240763000 USD
CY2012Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
77722000 USD
CY2012Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
72913000 USD
CY2012Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13767000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
15260000 USD
CY2012Q2 us-gaap Net Income Loss
NetIncomeLoss
22569000 USD
CY2011Q2 us-gaap Net Income Loss
NetIncomeLoss
24913000 USD
CY2012Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
14656000 USD
CY2012Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
210000 USD
CY2011Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
322000 USD
CY2012Q2 us-gaap Liabilities
Liabilities
1981655000 USD
CY2012Q1 us-gaap Liabilities
Liabilities
1991982000 USD
CY2012Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3864238000 USD
CY2012Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3834198000 USD
CY2012Q1 us-gaap Liabilities Current
LiabilitiesCurrent
600066000 USD
CY2012Q2 us-gaap Liabilities Current
LiabilitiesCurrent
602786000 USD
CY2012Q1 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1429000 USD
CY2012Q2 us-gaap Liabilities Of Disposal Group Including Discontinued Operation Current
LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent
1210000 USD
CY2012Q2 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
287000000 USD
CY2012Q1 us-gaap Line Of Credit Facility Amount Outstanding
LineOfCreditFacilityAmountOutstanding
298000000 USD
CY2012Q2 us-gaap Line Of Credit Facility Expiration Date
LineOfCreditFacilityExpirationDate
12/16/2016
CY2012Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
700000000 USD
CY2012Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
944908000 USD
CY2012Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
933971000 USD
CY2012Q2 us-gaap Long Term Investments
LongTermInvestments
1113000 USD
CY2012Q1 us-gaap Long Term Investments
LongTermInvestments
1105000 USD
CY2011Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3811000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10195000 USD
CY2011Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1903000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-10195000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5228000 USD
CY2011Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-64283000 USD
CY2011Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42651000 USD
CY2012Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15539000 USD
CY2011Q2 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
47280000 USD
CY2011Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Revenue
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetRevenue
-700000 USD
CY2012Q2 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Net Revenue
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetRevenue
-700000 USD
CY2011Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5756000 USD
CY2012Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12830000 USD
CY2011Q2 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
79100000 USD
CY2012Q2 us-gaap Notional Amount Of Foreign Currency Derivatives
NotionalAmountOfForeignCurrencyDerivatives
96500000 USD
CY2011Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
41431000 USD
CY2012Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
36382000 USD
CY2012Q1 us-gaap Other Assets Current
OtherAssetsCurrent
69023000 USD
CY2012Q2 us-gaap Other Assets Current
OtherAssetsCurrent
103380000 USD
CY2012Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41075000 USD
CY2012Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
41556000 USD
CY2008Q2 us-gaap Other Comprehensive Income Derivatives Qualifying As Hedges Tax Effect Period Increase Decrease
OtherComprehensiveIncomeDerivativesQualifyingAsHedgesTaxEffectPeriodIncreaseDecrease
5400000 USD
CY2011Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
47291000 USD
CY2012Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
13766000 USD
CY2011Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
47640000 USD
CY2012Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
14100000 USD
CY2012Q2 us-gaap Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-299000 USD
CY2011Q2 us-gaap Other Comprehensive Income Reclassification Adjustment On Derivatives Included In Net Income Net Of Tax
OtherComprehensiveIncomeReclassificationAdjustmentOnDerivativesIncludedInNetIncomeNetOfTax
-299000 USD
CY2011Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
50000 USD
CY2012Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
35000 USD
CY2012Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
447008000 USD
CY2012Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
444898000 USD
CY2012Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1603000 USD
CY2011Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2162000 USD
CY2011Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
109224000 USD
CY2012Q2 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1632000 USD
CY2012Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
279000 USD
CY2011Q2 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2011Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8106000 USD
CY2012Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
7922000 USD
CY2011Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7681000 USD
CY2012Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5228000 USD
CY2012Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2012Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2012Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000 shares
CY2012Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2012Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
111000000 USD
CY2011Q2 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
208000000 USD
CY2012Q2 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
0 USD
CY2011Q2 us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
-38000 USD
CY2012Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9499000 USD
CY2011Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
18030000 USD
CY2011Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8271000 USD
CY2012Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10412000 USD
CY2012Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
10749000 USD
CY2011Q1 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
8250000 USD
CY2011Q2 us-gaap Product Warranty Accrual Currency Translation Increase Decrease
ProductWarrantyAccrualCurrencyTranslationIncreaseDecrease
245000 USD
CY2012Q2 us-gaap Product Warranty Accrual Currency Translation Increase Decrease
ProductWarrantyAccrualCurrencyTranslationIncreaseDecrease
101000 USD
CY2012Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4847000 USD
CY2011Q2 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3427000 USD
CY2012Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
357194000 USD
CY2011Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
306126000 USD
CY2011Q2 us-gaap Sales Revenue Net
SalesRevenueNet
447178000 USD
CY2012Q2 us-gaap Sales Revenue Net
SalesRevenueNet
510890000 USD
CY2011Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
141052000 USD
CY2012Q2 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
153696000 USD
CY2011Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-125000 USD
CY2012Q2 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
457000 USD
CY2011Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3328000 USD
CY2012Q2 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4626000 USD
CY2012Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
458233000 USD
CY2012Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
451953000 USD
CY2012Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
174567000 USD
CY2012Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
171683000 USD
CY2011Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
118200000 USD
CY2012Q2 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
122000000 USD
CY2012Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32624000 USD
CY2011Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
26185000 USD
CY2012Q2 us-gaap Restructuring Charges
RestructuringCharges
6159000 USD
CY2011Q2 us-gaap Restructuring Charges
RestructuringCharges
0 USD
CY2012Q2 us-gaap Restructuring Reserve
RestructuringReserve
15056000 USD
CY2012Q1 us-gaap Restructuring Reserve
RestructuringReserve
13958000 USD
CY2012Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1525147000 USD
CY2012Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1510683000 USD
CY2011Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
132695000 USD
CY2012Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
156849000 USD
CY2011Q2 us-gaap Share Based Compensation
ShareBasedCompensation
3054000 USD
CY2012Q2 us-gaap Share Based Compensation
ShareBasedCompensation
5476000 USD
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.012
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.011
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
4
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
4
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.387
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.381
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.019
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
19200000 USD
CY2012Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1
4.0 years
CY2012Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
521000 shares
CY2012Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
114119000 shares
CY2011Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
115140000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.006
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3655000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
20.28
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm
3.0 years
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
18.22
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
203000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
22.21
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
4000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
12.95
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
686000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.15
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
22500000 USD
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5304000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5346000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
21.46
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
20.57
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
20500000 USD
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4843000 shares
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
21.46
CY2012Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm
4.0 years
CY2012Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
15000000 shares
CY2008Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
10000000 shares
CY2012Q2 us-gaap Stock Repurchase Program Remaining Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
6000000 shares
CY2012Q2 us-gaap Stockholders Equity
StockholdersEquity
1882583000 USD
CY2012Q1 us-gaap Stockholders Equity
StockholdersEquity
1842216000 USD
CY2012Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
49300000 USD
CY2012Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
43900000 USD
CY2012Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113097000 shares
CY2011Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
113998000 shares
CY2011Q2 pki Accrued Expenses And Other
AccruedExpensesAndOther
1473000 USD
CY2012Q2 pki Accrued Expenses And Other
AccruedExpensesAndOther
-35842000 USD
CY2012Q2 pki Accumulated Other Comprehensive Income Loss Cumulative Changes In Net Gain Loss From Cash Flow Hedges Effect Tax
AccumulatedOtherComprehensiveIncomeLossCumulativeChangesInNetGainLossFromCashFlowHedgesEffectTax
2500000 USD
CY2012Q2 pki Aggregate Cost Of Repurchased Common Shares For Statutory Tax Withholding Obligations
AggregateCostOfRepurchasedCommonSharesForStatutoryTaxWithholdingObligations
1600000 USD
CY2012Q2 pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
4495000 USD
CY2011Q2 pki Amortization Of Acquired Inventory Revaluation
AmortizationOfAcquiredInventoryRevaluation
110000 USD
CY2012 pki Change In Any One Of Input Assumptions For Various Reporting Units
ChangeInAnyOneOfInputAssumptionsForVariousReportingUnits
0.100
CY2012Q2 pki Duration Of Foreign Currency Derivatives
DurationOfForeignCurrencyDerivatives
30 days
CY2012 pki Duration Of Foreign Currency Derivatives
DurationOfForeignCurrencyDerivatives
30 days
CY2012Q2 pki Forward Foreign Exchange Contracts With Euro Equivalent Notional Amounts
ForwardForeignExchangeContractsWithEuroEquivalentNotionalAmounts
125000000 USD
CY2012Q1 pki Increase Decrease In Accrued Tax Provision Related To Repatriation Of Unremitted Foreign Earnings
IncreaseDecreaseInAccruedTaxProvisionRelatedToRepatriationOfUnremittedForeignEarnings
79700000 USD
CY2012Q2 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
827000 shares
CY2011Q2 pki Incremental Common Shares Attributable To Share Based Payment Arrangements Stock Options
IncrementalCommonSharesAttributableToShareBasedPaymentArrangementsStockOptions
1020000 shares
CY2011Q2 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
122000 shares
CY2012Q2 pki Incremental Common Shares Attributable To Share Based Payments Arrangements Restricted Stock Awards
IncrementalCommonSharesAttributableToShareBasedPaymentsArrangementsRestrictedStockAwards
195000 shares
CY2011Q2 pki New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Expenses
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingExpenses
-700000 USD
CY2012Q2 pki New Accounting Pronouncement Or Change In Accounting Principle Effect Of Change On Operating Expenses
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnOperatingExpenses
-700000 USD
CY2008Q2 pki Notional Amount Of Interest Rate Derivatives Settled
NotionalAmountOfInterestRateDerivativesSettled
150000000 USD
CY2012Q2 pki Number Of Former Stock Based Compensation Plans
NumberOfFormerStockBasedCompensationPlans
1
CY2012 pki Number Of Years In Measurement Period From Acquisition Date To Change Underlying Assumptions
NumberOfYearsInMeasurementPeriodFromAcquisitionDateToChangeUnderlyingAssumptions
1 years
CY2012Q2 pki Number Of Years Over Which Estimated Environmental Cost Will Be Paid
NumberOfYearsOverWhichEstimatedEnvironmentalCostWillBePaid
10 years
CY2012Q2 pki Open Tax Years By Major Tax Jurisdiction Begin Date
OpenTaxYearsByMajorTaxJurisdictionBeginDate
2003
CY2012Q2 pki Open Tax Years By Major Tax Jurisdiction End Date
OpenTaxYearsByMajorTaxJurisdictionEndDate
2011
CY2012Q2 pki Payments For Acquisition Related Contingent Consideration
PaymentsForAcquisitionRelatedContingentConsideration
0 USD
CY2011Q2 pki Payments For Acquisition Related Contingent Consideration
PaymentsForAcquisitionRelatedContingentConsideration
-137000 USD
CY2011Q2 pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
56602000 USD
CY2012Q2 pki Payments For Acquisitions And Investments Net Of Cash And Cash Equivalents Acquired
PaymentsForAcquisitionsAndInvestmentsNetOfCashAndCashEquivalentsAcquired
0 USD
CY2012Q2 pki Percentage Of Business Outside Domestic Country
PercentageOfBusinessOutsideDomesticCountry
0.62
CY2012Q2 pki Repatriated Foreign Earnings
RepatriatedForeignEarnings
161300000 USD
CY2012Q2 pki Repurchased Common Shares For Statutory Tax Withholding Obligations
RepurchasedCommonSharesForStatutoryTaxWithholdingObligations
64036 shares
CY2010Q3 pki Stock Repurchase Program Number Of Additional Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfAdditionalSharesAuthorizedToBeRepurchased
5000000 shares
CY2012Q2 pki Unrecognized Tax Benefits Expected To Be Resolved With In Year
UnrecognizedTaxBenefitsExpectedToBeResolvedWithInYear
9400000 USD
CY2012 pki Unremitted Earnings Planned To Be Repatriated
UnremittedEarningsPlannedToBeRepatriated
350000000 USD
CY2012Q2 dei Amendment Flag
AmendmentFlag
false
CY2012Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-30
CY2012Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2012Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2012
CY2012Q2 dei Document Period End Date
DocumentPeriodEndDate
2012-04-01
CY2012Q2 dei Document Type
DocumentType
10-Q
CY2012Q2 dei Entity Central Index Key
EntityCentralIndexKey
0000031791
CY2012Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
113886250 shares
CY2012Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2012Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012Q2 dei Entity Registrant Name
EntityRegistrantName
PERKINELMER INC
CY2012Q2 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2012Q2 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes

Files In Submission

Name View Source Status
0001445305-12-001561-index-headers.html Edgar Link pending
0001445305-12-001561-index.html Edgar Link pending
0001445305-12-001561.txt Edgar Link pending
0001445305-12-001561-xbrl.zip Edgar Link pending
a101employmentagreementbya.htm Edgar Link pending
a102employmentagreementbya.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
pki-20120401.xml Edgar Link completed
pki-20120401.xsd Edgar Link pending
pki-20120401_cal.xml Edgar Link unprocessable
pki-20120401_def.xml Edgar Link unprocessable
pki-20120401_lab.xml Edgar Link unprocessable
pki-20120401_pre.xml Edgar Link unprocessable
pki-4012012x10q.htm Edgar Link pending
pki-4012012xex_311.htm Edgar Link pending
pki-4012012xex_312.htm Edgar Link pending
pki-4012012xex_321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending